p-chloromercuribenzoic acid has been researched along with losartan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karamyan, VT; Speth, RC | 1 |
| Karamyan, VT; Speth, RC; Stockmeier, CA | 1 |
| Santos, KL; Speth, RC; Vento, MA; Wright, JW | 1 |
3 other study(ies) available for p-chloromercuribenzoic acid and losartan
| Article | Year |
|---|---|
Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain.
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Autoradiography; Binding, Competitive; Brain; Drug Interactions; Imidazoles; Iodine Isotopes; Losartan; p-Chloromercuribenzoic Acid; Pyridines; Rats; Rats, Sprague-Dawley | 2007 |
Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensins; Binding Sites; Binding, Competitive; Brain Chemistry; Cerebral Cortex; Female; Humans; Imidazoles; Ligands; Losartan; Male; Middle Aged; p-Chloromercuribenzoic Acid; Peptides; Protease Inhibitors; Pyridines; Radioligand Assay; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Sex Characteristics | 2008 |
The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysin.
Topics: Angiotensin I; Angiotensin II; Angiotensins; Animals; Binding Sites; Losartan; Male; Metalloendopeptidases; Oxidation-Reduction; p-Chloromercuribenzoic Acid; Rats; Sulfhydryl Compounds | 2013 |